drug
ascorbic acid
Marketedupdated 3mo agoby Renovion Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying ascorbic acid
- phase2A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery
- phase2A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
- phase1The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
- N/AThe Effect of Nutritional Supplementation on Actinic Purpura: A Pilot Study
- phase3Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®
- N/AeValuating iDA Selection Ability. The VISA Study.
- phase2Tolerance and Effectiveness of C14 on HPV Infection
- phase1Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 9, 2032
~5.6 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (11)
- Sep 10, 2033formulationUS 10016504
- Sep 10, 2033method-of-use (U-2310)US 10918723
- Sep 10, 2033formulationUS 12083179
- Sep 10, 2033formulationUS 8999313
- Sep 10, 2033method-of-use (U-2310)US 9326969
- Sep 10, 2033formulationUS 9707297
- Aug 11, 2032formulationUS 9592252
- Mar 25, 2032formulationUS 10646512
- Mar 9, 2032formulationUS 10780112
- Mar 9, 2032formulationUS 10792306
- Mar 9, 2032formulationUS 11529368
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that